OBJECTIVE: This study examines the physiological impact of a glucose load on serum testosterone (T) levels in men with varying glucose tolerance (GT). DESIGN: Cross-sectional study. PATIENTS AND METHODS: 74 men (19-74 years, mean 51·4 ± 1·4 years) underwent a standard 75-g oral glucose tolerance test with blood sampling at 0, 30, 60, 90 and 120 min. Fasting serum glucose, insulin, total T (and calculated free T), LH, SHBG, leptin and cortisol were measured. RESULTS: 57% of the men had normal GT, 30% had impaired GT and 13% had newly diagnosed type 2 diabetes. Glucose ingestion was associated with a 25% decrease in mean T levels (delta = -4·2 ± 0·3 nm, P < 0·0001). T levels remained suppressed at 120 min compared with baseline (13·7 ± 0·6 vs 16·5 ± 0·7 nm, P < 0·0001) and did not differ across GT or BMI. Of the 66 men with normal T levels at baseline, 10 (15%) had levels that decreased to the hypogonadal range (<9·7 nm) at one or more time points. SHBG, LH and cortisol levels were unchanged. Leptin levels decreased from baseline at all time points (P < 0·0001). CONCLUSIONS: Glucose ingestion induces a significant reduction in total and free T levels in men, which is similar across the spectrum of glucose tolerance. This decrease in T appears to be because of a direct testicular defect, but the absence of compensatory changes in LH suggests an additional central component. Men found to have low nonfasting T levels should be re-evaluated in the fasting state.
OBJECTIVE: This study examines the physiological impact of a glucose load on serum testosterone (T) levels in men with varying glucose tolerance (GT). DESIGN: Cross-sectional study. PATIENTS AND METHODS: 74 men (19-74 years, mean 51·4 ± 1·4 years) underwent a standard 75-g oral glucose tolerance test with blood sampling at 0, 30, 60, 90 and 120 min. Fasting serum glucose, insulin, total T (and calculated free T), LH, SHBG, leptin and cortisol were measured. RESULTS: 57% of the men had normal GT, 30% had impaired GT and 13% had newly diagnosed type 2 diabetes. Glucose ingestion was associated with a 25% decrease in mean T levels (delta = -4·2 ± 0·3 nm, P < 0·0001). T levels remained suppressed at 120 min compared with baseline (13·7 ± 0·6 vs 16·5 ± 0·7 nm, P < 0·0001) and did not differ across GT or BMI. Of the 66 men with normal T levels at baseline, 10 (15%) had levels that decreased to the hypogonadal range (<9·7 nm) at one or more time points. SHBG, LH and cortisol levels were unchanged. Leptin levels decreased from baseline at all time points (P < 0·0001). CONCLUSIONS:Glucose ingestion induces a significant reduction in total and free T levels in men, which is similar across the spectrum of glucose tolerance. This decrease in T appears to be because of a direct testicular defect, but the absence of compensatory changes in LH suggests an additional central component. Men found to have low nonfasting T levels should be re-evaluated in the fasting state.
Authors: Thiago Gagliano-Jucá; Zhuoying Li; Karol M Pencina; Yusnie M Beleva; Olga D Carlson; Josephine M Egan; Shehzad Basaria Journal: Endocrine Date: 2018-09-06 Impact factor: 3.633
Authors: David Bann; Frederick C W Wu; Brian Keevil; Hany Lashen; Judith Adams; Rebecca Hardy; Graciela Muniz; Diana Kuh; Yoav Ben-Shlomo; Ken K Ong Journal: Obesity (Silver Spring) Date: 2015-06-05 Impact factor: 5.002
Authors: Bruno Lunenfeld; George Mskhalaya; Michael Zitzmann; Stefan Arver; Svetlana Kalinchenko; Yuliya Tishova; Abraham Morgentaler Journal: Aging Male Date: 2015-02-06 Impact factor: 5.892
Authors: Entesar Oa El Saghier; Salah E Shebl; Olfat A Fawzy; Ihab M Eltayeb; Lamya Ma Bekhet; Abdelnasser Gharib Journal: Clin Med Insights Endocrinol Diabetes Date: 2015-07-19
Authors: Ronald Wiehle; Glenn R Cunningham; Nelly Pitteloud; Jenny Wike; Kuang Hsu; Gregory K Fontenot; Michele Rosner; Andrew Dwyer; Joseph Podolski Journal: BJU Int Date: 2013-07-12 Impact factor: 5.588
Authors: Georgios K Dimitriadis; Harpal S Randeva; Saboor Aftab; Asad Ali; John G Hattersley; Sarojini Pandey; Dimitris K Grammatopoulos; Georgios Valsamakis; Georgios Mastorakos; T Hugh Jones; Thomas M Barber Journal: Endocrine Date: 2018-02-02 Impact factor: 3.633